Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Terminalcare Support InstituteTSE:7362 +0.47%69 Debt-to-EBITDA is 3.27 as of Dec. 2025, which is 57% below its 10-year median of 7.63. GuruFocus rates TSE:7362 with a GF Score™ of 69/100 and a GF Value™ of 円1,170.04 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Terminalcare Support Institute ranks worse than 88.49% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Terminalcare Support Institute's Debt-to-EBITDA or its related term are showing as below:
TSE:7362'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 4.01 Med: 7.63 Max: 9.96
Current: 9.23
During the past 8 years, the highest Debt-to-EBITDA Ratio of Terminalcare Support Institute was 9.96. The lowest was 4.01. And the median was 7.63.
TSE:7362's Debt-to-EBITDA is ranked worse than 88.49% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.195
vs TSE:7362: 9.23
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Terminalcare Support Institute Debt-to-EBITDA Related Terms
Terminalcare Support Institute Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terminalcare Support Institute Debt-to-EBITDA Chart
TSE:7362 vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Terminalcare Support Institute's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Terminalcare Support Institute Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Terminalcare Support Institute's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Terminalcare Support Institute's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Dec. 2025) EBITDA data.
Terminalcare Support Institute (TSE:7362) has a Debt-to-EBITDA of 3.27 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Terminalcare Support Institute. This is 57% below median its historical median of 7.63. Over the past decade, Terminalcare Support Institute's Debt-to-EBITDA has ranged from 4.01 to 9.96. According to the industry distribution chart, Terminalcare Support Institute ranks #423 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 88.5%.
Is Terminalcare Support Institute's Debt-to-EBITDA too high?
Terminalcare Support Institute's current Debt-to-EBITDA of 3.27 is 57% below median its 10-year median of 7.63. Over the past 10 years, this metric has ranged from a low of 4.01 to a high of 9.96. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.20. Terminalcare Support Institute's value of 3.27 is 49% above this industry median. Based on the distribution chart, Terminalcare Support Institute ranks #423 out of 478 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Terminalcare Support Institute has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terminalcare Support Institute's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Terminalcare Support Institute ranks #423 out of 478 companies for Debt-to-EBITDA. This places Terminalcare Support Institute in the lower half of its industry. The industry median Debt-to-EBITDA is 2.20. Terminalcare Support Institute's value of 3.27 is 49% above this benchmark. Historically, Terminalcare Support Institute's own Debt-to-EBITDA has ranged from 4.01 to 9.96 over the past decade. While the company's 10-year median is 7.63 vs. the industry median of 2.20, Terminalcare Support Institute has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.20, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Terminalcare Support Institute's current Debt-to-EBITDA of 3.27 is 49% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Terminalcare Support Institute. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Terminalcare Support Institute's current Debt-to-EBITDA is 3.27, which is 57% below median its own 10-year median of 7.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terminalcare Support Institute stock overvalued right now?
Based on GuruFocus' analysis, Terminalcare Support Institute (TSE:7362) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,170.04, compared to a current price of 円860.00 — trading 26.5% below its estimated fair value. The current Debt-to-EBITDA is 3.27, which is 57% below median its 10-year median of 7.63 and 49% above the Healthcare Providers & Services industry median of 2.20. Terminalcare Support Institute's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Terminalcare Support Institute (TSE:7362), the current Debt-to-EBITDA is 3.27 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Terminalcare Support Institute (TSE:7362) Overvalued in 2026?
Based on GuruFocus' analysis, Terminalcare Support Institute stock appears to be undervalued.
The current stock price of 円860.00 is trading 26.5% below its estimated GF Value™ of 円1,170.04.
GuruFocus considers Terminalcare Support Institute to be Modestly Undervalued.
Key valuation signals for TSE:7362:
Debt-to-EBITDA: 3.27 (57% below median its 10-year median of 7.63)
GF Value™: 円1,170.04 vs. price of 円860.00 (26.5% below fair value)
Industry Position: 49% above the Healthcare Providers & Services median (#423 of 478)
No single metric tells the full story. See the TSE:7362 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Terminalcare Support Institute Inc is engaged in building elderly housing with supportive services and providing home-care services. The company is also engaged in the Real estate business in which company provides construction contracting, real estate sales, and real estate rental services. The company derives key revenue from the Nursing business.
69GF Score
Get the complete analysis for TSE:7362
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7362 has been successfully added to your 
